<?xml version="1.0" encoding="UTF-8"?>
<p>To confirm that 5-LOX is involved in the daidzein-induced antiviral activity, we examined the effect of inhibitors of 5-LOX on antiviral activity. The antiviral activity of daidzein was significantly reduced following treatment with zileuton, a selective direct inhibitor of 5-LOX (Fig. 
 <xref ref-type="fig" rid="F4">4</xref>A). Daidzein-induced inhibition of virus replication was decreased in the presence of zileuton from 72% [flu: flu + daidzein, inhibition rate = 100 – 100 × 0.58 × 10
 <sup>6</sup>/2.1 × 10
 <sup>6</sup> (%)] to 51% [flu + zileuton: flu + daidzein + zileuton, inhibition rate = 100 – 100 × 1.2 × 10
 <sup>6</sup>/2.5 × 10
 <sup>6</sup> (%)] (Fig. 
 <xref ref-type="fig" rid="F4">4</xref>A). The virus titer was increased by zileuton to 212% [flu + daidzein: flu + daidzein + zileuton, activation rate = 100 × 1.2 × 10
 <sup>6</sup>/0.58 × 10
 <sup>6</sup> (%)] (Fig. 
 <xref ref-type="fig" rid="F4">4</xref>A). Zileuton tended to reduce daidzein-induced 5-HETE production, but the reduction was not significant (Fig. 
 <xref ref-type="fig" rid="F4">4</xref>B).
</p>
